Ensuring that Xpert® MTB/RIF is used to its maximum potential
- PMID: 31615615
- PMCID: PMC8896394
- DOI: 10.5588/ijtld.19.0082
Ensuring that Xpert® MTB/RIF is used to its maximum potential
Conflict of interest statement
Comment in
-
Implementation of Xpert® MTB/RIF: real challenges, real promise.Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1123. doi: 10.5588/ijtld.19.0120. Int J Tuberc Lung Dis. 2019. PMID: 31627779 Free PMC article. No abstract available.
Comment on
-
Xpert at 8 years: where are we now, and what should we do next?Int J Tuberc Lung Dis. 2019 Jan 1;23(1):3-4. doi: 10.5588/ijtld.18.0717. Int J Tuberc Lung Dis. 2019. PMID: 30674373 Free PMC article. No abstract available.
-
Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.Int J Tuberc Lung Dis. 2019 Jan 1;23(1):82-92. doi: 10.5588/ijtld.18.0203. Int J Tuberc Lung Dis. 2019. PMID: 30674379 Free PMC article.
References
-
- Kweza PF, Van Schalkwyk C, Abraham N, et al. Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa. Int J Tuberc Lung Dis 2018; 22: 264–272. - PubMed
-
- Takarinda KC, Choto R, Sandy C, et al. How well does the process of screening and diagnosis work for HIV-infected persons identified with presumptive tuberculosis who are attending HIV care and treatment clinics in Harare city, Zimbabwe? Trans R Soc Trop Med Hyg 2018; 112: 450–457. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources